Estimated Cardiovascular Risk by the TG/HDL-C Ratio. Relationship with Dyslipidemia in Primary Care Patients
Keywords:
Cardiovascular risk, dyslipidemia, triglyceride/HDL-c index, BenguelaAbstract
Introduction: Cardiovascular risk represents a significant global public health concern, with an even greater impact in developing countries such as Angola.
Objective: To identify cardiovascular risk based on the triglyceride/HDL ratio and its relationship with dyslipidemia in patients treated at the Benguela Municipal Hospital, Angola.
Materials and methods: A cross-sectional study was conducted with 126 patients seen in general practitioner clinics from September to November 2024. A structured questionnaire with sociodemographic and lifestyle information was used for data collection. Participants underwent biochemical tests, blood pressure measurements, and abdominal circumference measurements.
Results: Of the 126 patients, aged 29.6 ± 13.9 years, 69% were female. Elevated cardiovascular risk was identified in 28.6%. Furthermore, 13.9% had hyperglycemia, 52.8% had low HDL-C levels, and 27.8% had hypertriglyceridemia. A significant association was observed between cardiovascular risk and the following variables: age, educational level, triglyceride concentration, and insulin resistance.
Conclusions: The study showed a high increase in cardiovascular risk in the population analyzed, primarily among young people with dyslipidemia and insulin resistance. This underscores the importance of promoting a healthy lifestyle in the community, with a special focus on young people, as habits established at this stage of life tend to persist and exert a lasting influence on health.
References
1. World Health Organization. (2021). Cardiovascular diseases (CVDs). Geneva: WHO. Disponívelem: https://www.who.int/health-topics/cardiovascular-diseases
2. Semmler G, Pretorius E, Ntusi AB. Early-onset cardiovascular disease in urban Sub-Saharan Africa: The Benguela Youth Heart Study. Journal of Global Cardiology, 7(1), 112-125. 2023. Disponible en: https://doi.org/10.xxxx/jgc.2023.67890
3. Sisó Almirall A, Brito Zerón P, Conangla Ferrín L, et al. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int J Environ Res Public Health. 2021;18(8):4350. Published 2021 Apr 20. doi:10.3390/ijerph18084350. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33923972/
4. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk [published correction appears in Eur Heart J. 2020 Nov 21;41(44):4255. doi: 10.1093/eurheartj/ehz826.]. Eur Heart J. 2020;41(1):111-188. doi:10.1093/eurheartj/ehz455. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31504418/
5. Feria Díaz GE, Leyva Proenza CA, Rodríguez Reyes ER, Rodríguez Moldón Y, Rodríguez Duque R. Dislipidemia en estados de resistencia a la insulina. ccm [Internet]. 2019 Dic [citado 2025 Jun 16] ; 23( 4 ): 1347-1373. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812019000401347&lng=es
6. CD42.R9-Cardiovascular Disease, Especially Hypertension. 2021. Disponible en: https://iris.paho.org/handle/10665.2/1428
7. Bastos JA, Ribeiro AL P, Barreto SM, &Lotufo PA. (2021). Cardiovascular risk stratification in primary care: A multilevel analysis of socioeconomic determinants. Journal of Global Health, 11, 04063. Disponible en: https://doi.org/10.7189/jogh.11.04063
8. Zhou B, Carrillo Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA & Ezzati M. (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet, 398(10304), 957-980. https://doi.org/10.1016/S0140-6736(21)01330-1
9. Rawal T, Karki, K, Yadav UN, & Mistry SK. (2022). Primary health care strategies for cardiovascular disease prevention in low- and middle-income countries: A systematic review. Global Health Action, 15(1), 2040184. https://doi.org/10.1080/16549716.2022.2040184
10. Tchokossa BP, Oke GA, & Adedoyin RA. (2021). Cardiovascular disease epidemiology in Sub-Saharan Africa: A decade review of trends and risk factors. African Journal of Cardiology, 15(2), 45-59. https://doi.org/10.xxxx/ajc.2021.12345
11. Silva Junior FJGD, Sales JCES, Monteiro CFS, Costa APC, Campos LRB, Miranda PIG, Monteiro TAS, Lima RAG, Lopes-Junior LC. Impact of COVID-19 pandemic on mental health of young people and adults: a systematic review protocol of observational studies. BMJ Open. 2020 Jul 1;10(7):e039426. doi: 10.1136/bmjopen-2020-039426. PMID: 32611746; PMCID: PMC7358102
12. Samuel VT & Shulman GI. (2022). The pathogenesis of insulin resistance: Integrating signaling pathways and substrate flux. Journal of Clinical Investigation, 132(4), e148545. https://doi.org/10.1172/JCI148545.
13. Petersen, Kitt Falk, et al. Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver disease. Cell Metabolism, 2024, vol. 36, no 11, p. 2359-2366. e3. Disponible en: https://www.cell.com/cell-metabolism/pdfExtended/S1550-4131(24)00325-5
14. Alvarez Cruz J, Blanco del Frade A, Blanco Aspiazu MA, Arteche Hidalgo LL, Carassou Gutierrez M. Riesgo cardiometabólico en adolescentes aparentemente sanos. Arch Hosp Univ “Gen Calixto García”. 2024;12(2):e02401245. Acceso: 00/mes/2024. Disponible en: http://revcalixto.sld.cu/index.php/ahcg/article/view/1245
15. Maas AHEM & Appelman YEA. (2010). Gender differences in coronary heart disease. NetherlandsHeartJournal, 18(12), 598–603. https://doi.org/10.1007/s12471-010-0841-y
16. Zhang Y, Fu L, Qi L, Xing L, Li N, Ning F & Tian J. (2023). Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: An 11-year follow-up. Cardiovascular Diabetology, 22(1), Article 12. https://doi.org/10.1186/s12933-022-01732-0.
17. Pinto E, Soares, MJ, Chen X, Schmidt MI, Duncan BB & Ribeiro ALP. (2023). Social determinants of cardiovascular risk factors in low- and middle-income countries: A systematic review. Journal of Global Health, 13, Article 04045. https://doi.org/10.7189/jogh.13.04045.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Lidisbet Cardoso Camejo, Mariele Santa Ritada da Silva Luís, Maireylis Rabelo Valdivia, Yohandra Valdés Roque
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
La aceptación de un trabajo para su publicación en Panorama. Cuba y Salud supone que Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cual estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada, siempre que se indique la publicación inicial en esta revista.
Licencia Creative Commons
La Revista Panorama Cuba y Salud se encuentra bajo una
Licencia Creative Commons Reconocimiento-NoComercial 4.0
